Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Tammy Sobolik"'
Autor:
Yan Liu, Oriana E. Hawkins, Yingjun Su, Anna E. Vilgelm, Tammy Sobolik, Yee‐Mon Thu, Sara Kantrow, Ryan C. Splittgerber, Sarah Short, Katayoun I. Amiri, Jeffery A. Ecsedy, Jeffery A. Sosman, Mark C. Kelley, Ann Richmond
Publikováno v:
EMBO Molecular Medicine, Vol 5, Iss 1, Pp 149-166 (2012)
Abstract Oncogene‐induced senescence can provide a protective mechanism against tumour progression. However, production of cytokines and growth factors by senescent cells may contribute to tumour development. Thus, it is unclear whether induction o
Externí odkaz:
https://doaj.org/article/3ceb4ec9997e4c1aa310a31385394045
Autor:
Meghan M Morrison, Christian D Young, Shan Wang, Tammy Sobolik, Violeta M Sanchez, Donna J Hicks, Rebecca S Cook, Dana M Brantley-Sieders
Publikováno v:
PLoS Genetics, Vol 11, Iss 7, p e1005291 (2015)
Akt phosphorylation is a major driver of cell survival, motility, and proliferation in development and disease, causing increased interest in upstream regulators of Akt like mTOR complex 2 (mTORC2). We used genetic disruption of Rictor to impair mTOR
Externí odkaz:
https://doaj.org/article/5f213725e78f4caa83a26de4ea6cc6bf
Autor:
Christine M Lovly, Kimberly Brown Dahlman, Laurel E Fohn, Zengliu Su, Dora Dias-Santagata, Donna J Hicks, Donald Hucks, Elizabeth Berry, Charles Terry, MarKeesa Duke, Yingjun Su, Tammy Sobolik-Delmaire, Ann Richmond, Mark C Kelley, Cindy L Vnencak-Jones, A John Iafrate, Jeffrey Sosman, William Pao
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35309 (2012)
Knowledge of tumor mutation status is becoming increasingly important for the treatment of cancer, as mutation-specific inhibitors are being developed for clinical use that target only sub-populations of patients with particular tumor genotypes. Mela
Externí odkaz:
https://doaj.org/article/c2f35af3ee7c4c6987cfa14245f98a46
Autor:
Nicole F Neel, Jiqing Sai, Amy-Joan L Ham, Tammy Sobolik-Delmaire, Raymond L Mernaugh, Ann Richmond
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23813 (2011)
Chemotaxis is essential for a number of physiological processes including leukocyte recruitment. Chemokines initiate intracellular signaling pathways necessary for chemotaxis through binding seven transmembrane G protein-couple receptors. Little is k
Externí odkaz:
https://doaj.org/article/2bab39ab5da447f18f05055eca573578
Autor:
Ann Richmond, Mark Boothby, Harold L. Moses, Ingrid A. Mayer, Melinda Sanders, Mark C. Kelley, Gregory D. Ayers, Colt McClain, Andrew C. Johnson, Nicole Lavender, Tammy Sobolik, Jinming Yang, Anna E. Vilgelm, Oriana E. Hawkins, Sergey V. Novitskiy, Philip Owens, Jiqing Sai
This file describes additional methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131e542ea51fe21cdf507397fb0097d3
https://doi.org/10.1158/1078-0432.22462245
https://doi.org/10.1158/1078-0432.22462245
Autor:
Ann Richmond, Mark Boothby, Harold L. Moses, Ingrid A. Mayer, Melinda Sanders, Mark C. Kelley, Gregory D. Ayers, Colt McClain, Andrew C. Johnson, Nicole Lavender, Tammy Sobolik, Jinming Yang, Anna E. Vilgelm, Oriana E. Hawkins, Sergey V. Novitskiy, Philip Owens, Jiqing Sai
Supplementary Figure 1: BKM120 inhibited CD4+ T cell, not CD8+ T cell proliferation and had small effects on PyMT specific T cell mediated cytotoxicity only at a 1:50 E/T cell ratio. Supplementary Figure 2: Tumors were initiated as described in Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1023a7d3ea5e15ff49781e8c208d2a27
https://doi.org/10.1158/1078-0432.22462248.v1
https://doi.org/10.1158/1078-0432.22462248.v1
Autor:
Ann Richmond, Jeffrey A. Sosman, Shawn Levy, Darrin D. Stuart, Yu Shyr, Pengcheng Lu, Aixiang Jiang, Katayoun I. Amiri, Kimberly Brown Dahlman, Snjezana Zaja-Milatovic, Tammy Sobolik, Sarah P. Short, Ryan C. Splittgerber, Sara Kantrow, Kelli L. Boyd, Yan Liu, Oriana E. Hawkins, Mark C. Kelley, Anna E. Vilgelm, Yingjun Su
PDF file - 1.2MB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1193ac0b5b24895ca3843e6d5be48b75
https://doi.org/10.1158/1078-0432.22443869
https://doi.org/10.1158/1078-0432.22443869
Autor:
Ann Richmond, Jeffrey A. Sosman, Shawn Levy, Darrin D. Stuart, Yu Shyr, Pengcheng Lu, Aixiang Jiang, Katayoun I. Amiri, Kimberly Brown Dahlman, Snjezana Zaja-Milatovic, Tammy Sobolik, Sarah P. Short, Ryan C. Splittgerber, Sara Kantrow, Kelli L. Boyd, Yan Liu, Oriana E. Hawkins, Mark C. Kelley, Anna E. Vilgelm, Yingjun Su
Purpose: The purpose of this preclinical study was to determine the effectiveness of RAF265, a multikinase inhibitor, for treatment of human metastatic melanoma and to characterize traits associated with drug response.Experimental Design: Advanced me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684a8f0d200c3ae27c63ddee35735568
https://doi.org/10.1158/1078-0432.c.6519989
https://doi.org/10.1158/1078-0432.c.6519989
Autor:
Ann Richmond, Mark Boothby, Harold L. Moses, Ingrid A. Mayer, Melinda Sanders, Mark C. Kelley, Gregory D. Ayers, Colt McClain, Andrew C. Johnson, Nicole Lavender, Tammy Sobolik, Jinming Yang, Anna E. Vilgelm, Oriana E. Hawkins, Sergey V. Novitskiy, Philip Owens, Jiqing Sai
Purpose: Metastatic breast cancers continue to elude current therapeutic strategies, including those utilizing PI3K inhibitors. Given the prominent role of PI3Kα,β in tumor growth and PI3Kγ,δ in immune cell function, we sought to determine whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49cf3e3a268adaab339768ddbc400af
https://doi.org/10.1158/1078-0432.c.6525051
https://doi.org/10.1158/1078-0432.c.6525051
Autor:
Matthew E. Burow, Ann Richmond, Mien-Chie Hung, Tyler J. Curiel, Rebecca A. Worthylake, Paul Dent, Kenneth P. Nephew, Suzanne A. Fuqua, Charles E. Wood, Barbara S. Beckman, Scott Wadsworth, Bridgette M. Collins-Burow, Snjezana Zaja-Milatovic, Linda W. Horton, Tammy Sobolik-Delmaire, Syreeta L. Tilghman, Chris Segar, Melyssa R. Bratton, Juan P. Fonseca, Shannon E. Muir, Menghong Sun, Dihua Yu, Yongkun Wei, Steven Elliott, Yun Zhu, Virgilio A. Salvo, Nicole F. Neel, Sarah P. Short, Lyndsay V. Rhodes
Supplementary Figure 3 from Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a541c71d5e656402ef246f10b589fbe8
https://doi.org/10.1158/0008-5472.22387998.v1
https://doi.org/10.1158/0008-5472.22387998.v1